Ex-McDermott, Dorsey Attys Face Insider Trading Trial

Law360, New York (September 24, 2009, 4:25 PM EDT) -- A former corporate partner at Dorsey & Whitney LLP and a former corporate partner at McDermott Will & Emery LLP have been committed to stand trial at London's Southwark Crown Court on eight counts of insider trading related to Novartis AG's $589 million takeover of drugmaker Neutec Pharma PLC.

Former Dorsey & Whitney partner Andrew Rimmington, former McDermott Will partner Michael McFall and former Neutec Pharma finance director Andrew King were remanded on bail to appear at Southwark Crown Court for a plea and case management...
To view the full article, register now.